Skip to main content
. Author manuscript; available in PMC: 2022 Oct 31.
Published in final edited form as: Lancet Glob Health. 2020 Aug;8(8):e1071–e1080. doi: 10.1016/S2214-109X(20)30240-0

Figure 5: CEACs for countries in each region.

Figure 5:

CEACs for each country in Africa, Asia and the Middle East, and Latin America. Each CEAC plot shows the proportion of simulations (y axis) where MNPs are cost-effective at a particular cost-effectiveness threshold value (x axis). Countries where the cumulative probability does not reach 1·0 are those in which the non-depicted simulations showed a net harm (and hence where cost-effectiveness could not be calculated). CEACs for each country are shown in the appendix (pp 120–22). CEAC=cost-effectiveness acceptability curve.